Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Brodalumab, sold under the brand name Siliq in the US and Kyntheum in the EU, is a human monoclonal antibody designed for the treatment of inflammatory diseases.
History, Mechanism of action & Overview
Explore the main themes, entities and connections around Brodalumab. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
us antibody amgen astrazeneca human siliq kyntheum eu fda compound rights sold treatment february 2017 approval moderate severe psoriasis mechanism
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Brodalumab | ATC code | L04AC12 (WHO) | 1.00 | infobox |
| Brodalumab | CAS Number | 1174395-19-7 Y | 1.00 | infobox |
| Brodalumab | ChemSpider | none | 1.00 | infobox |
| Brodalumab | DrugBank | DB11776 Y | 1.00 | infobox |
| Brodalumab | Formula | C6372H9840N1712O1988S52 | 1.00 | infobox |
| Brodalumab | KEGG | D10061 N | 1.00 | infobox |
| Brodalumab | Legal status | CA: ℞-only / Schedule D | 1.00 | infobox |
| Brodalumab | Legal status | US: ℞-only | 1.00 | infobox |
| Brodalumab | Legal status | EU: Rx-only | 1.00 | infobox |
| Brodalumab | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Brodalumab | License data | US DailyMed: Brodalumab | 1.00 | infobox |
| Brodalumab | Molar mass | 143905.93 g·mol−1 | 1.00 | infobox |
| Brodalumab | Other names | KHK4827, AMG 827 | 1.00 | infobox |
| Brodalumab | Source | Human | 1.00 | infobox |
| Brodalumab | Target | Interleukin 17 receptor A | 1.00 | infobox |
| Brodalumab | Trade names | Siliq, Kyntheum, Lumicef | 1.00 | infobox |
| Brodalumab | Type | Whole antibody | 1.00 | infobox |
| Brodalumab | UNII | 6ZA31Y954Z | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.